VREO — Vireo Growth Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapValue Trap

Annual balance sheet for Vireo Growth, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	15.2	15.1	16	91.6	103
Net Total Accounts Receivable
Net Total Receivables	4.5	4.29	19.1	16.6	116
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	41.6	46.7	149	230	305
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	108	95.7	25.3	40.2	271
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	167	159	183	279	817
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	16.4	29.7	179	135	192
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	124	156	199	223	510
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	43	3.44	-16	55.6	307
Total Liabilities & Shareholders' Equity	167	159	183	279	817
Total Common Shares Outstanding